Vascular Ehlers-Danlos Syndrome (VEDS) is a rare autosomal dominant collagen vascular disorder. Different from other Ehler-Danlos Syndrome subtypes, VEDS has poor prognosis due to severe fragility of connective tissues and association with life-threatening vascular and gastrointestinal complications. Spontaneous splenic rupture is a rare but hazardous complication related to this syndrome. To date, only 2 cases have been reported in the literature. Here we present another case of this uncommon complication, occurring in a 54-year-old woman in clinical follow-up for VEDS who presented with sudden onset of abdominal pain and hypotension.
MizunoKBoudkoSEngelJBachingerHP. Vascular Ehlers-Danlos syndrome mutations in type III collagen differently stall the triple helical folding. J Biol Chem. 2013;288(26):19166–19176.
2.
GermainDPHerrera-GuzmanY. Vascular Ehlers-Danlos syndrome. Ann Genet. 2004;47(1):1–9.
3.
AbayazeedAHaymanEMoghadamfalahiMCainD. Vascular type Ehlers-Danlos Syndrome with fatal spontaneous rupture of a right common iliac artery dissection: case report and review of literature. J Radiol Case Rep. 2014;8(2):63–69.
4.
HarrisSCSlaterDNAustinCA. Fatal splenic rupture in Ehlers-Danlos syndrome. Postgrad Med J. 1985;61(713):259–260.
5.
PriviteraAMilkhuCDattaVSayeghMCohenRWindsorA. Spontaneous rupture of the spleen in type IV Ehlers-Danlos syndrome: report of a case. Surg Today. 2009;39(1):52–54.
6.
ShalhubSBlackJHIIICecchiAC. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes. J Vasc Surg. 2014;60(1):160–169.
7.
OderichGSPannetonJMBowerTC. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42(1):98–106.
8.
GermainDP. Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis. 2007:2:32.
9.
PopeFMNarcisiPNichollsACGermaineDPalsGRichardsAJ. COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture. Br J Dermatol. 1996;135(2):163–181.
10.
GermainDP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2002;16(3):391–397.
11.
PepinMGByersPH. Ehlers-Danlos Syndrome Type IV. In: PagonRAAdamMPArdingerHH., eds. GeneReviews(R). Seattle, WA; University of Washington; 1993, 1–24.
12.
OderichGS. Current concepts in the diagnosis and management of vascular Ehlers-Danlos syndrome. Perspect Vasc Surg Endovasc Ther. 2006;18(3):206–214.
13.
PepinMSchwarzeUSuperti-FurgaAByersPH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342(10):673–680.
14.
LalASinghalMSharmaNBhallaAKhandelwalN. Isolated splenic peliosis with spontaneous rupture after a viperine bite. Am J Emerg Med. 2014;32(2):194. e3–e4.
15.
TsokosMErbersdoblerA. Pathology of peliosis. Forensic science international2005;149(1):25–33.
16.
van BonACKristinssonJOvan KriekenJHWantenGJ. Concurrent splenic peliosis and vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2009;23(2):256. e1–e4.
17.
BergqvistDBjorckMWanhainenA. Treatment of vascular Ehlers-Danlos syndrome: a systematic review. Ann Surg. 2013;258(2):257–261.
18.
OngKTPerduJDe BackerJ. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376(9751):1476–1484.
